Medifast, Inc.
MED
$13.65
-$0.44-3.12%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -15.10% | -16.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.10% | -16.85% | |||
| Cost of Revenue | -10.74% | -23.56% | |||
| Gross Profit | -16.52% | -14.39% | |||
| SG&A Expenses | -15.87% | -21.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.32% | -21.75% | |||
| Operating Income | -66.33% | 126.74% | |||
| Income Before Tax | -19.20% | 114.82% | |||
| Income Tax Expenses | 5.57% | 117.99% | |||
| Earnings from Continuing Operations | -29.05% | 113.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -29.05% | 113.85% | |||
| EBIT | -66.33% | 126.74% | |||
| EBITDA | 75.67% | 146.09% | |||
| EPS Basic | -29.07% | 113.84% | |||
| Normalized Basic EPS | -19.18% | 114.82% | |||
| EPS Diluted | -30.10% | 113.33% | |||
| Normalized Diluted EPS | -19.24% | 114.77% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | 2.81% | |||
